(Q36691067)

15 August 2017

1 reference

title

Aminoglycoside-induced translational read-through in disease: overcoming nonsense mutations by pharmacogenetic therapy (English)

1 reference

15 August 2017

Zingman LV

1

1 reference

15 August 2017

Park S

2

1 reference

15 August 2017

Olson TM

3

1 reference

15 August 2017

Alekseev AE

4

1 reference

15 August 2017

Terzic A

5

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 January 2007

1 reference

Clinical Pharmacology & Therapeutics

15 August 2017

published in

1 reference

15 August 2017

volume

81

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

99-103

1 reference

Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100012

Killing the messenger: new insights into nonsense-mediated mRNA decay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100012

7 January 2021

Searching for the 1 in 2,400,000: a review of dystrophin gene point mutations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100012

7 January 2021

Pharmacologic approaches to correcting the basic defect in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100012

7 January 2021

Nonsense-mediated decay approaches the clinic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100012

7 January 2021

Mechanism of action of streptomycin in E. coli: interruption of the ribosome cycle at the initiation of protein synthesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100012

7 January 2021

Structural origins of gentamicin antibiotic action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100012

7 January 2021

Recognition of cognate transfer RNA by the 30S ribosomal subunit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100012

7 January 2021

Basis for prokaryotic specificity of action of aminoglycoside antibiotics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100012

7 January 2021

Suppression of a nonsense mutation in mammalian cells in vivo by the aminoglycoside antibiotics G-418 and paromomycin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100012

7 January 2021

Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100012

7 January 2021

Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100012

7 January 2021

Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100012

7 January 2021

Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAs in a mammalian translation system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100012

7 January 2021

Sequence specificity of aminoglycoside-induced stop condon readthrough: potential implications for treatment of Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100012

7 January 2021

The efficiency of translation termination is determined by a synergistic interplay between upstream and downstream sequences in Saccharomyces cerevisiae.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100012

7 January 2021

Impact of the six nucleotides downstream of the stop codon on translation termination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100012

7 January 2021

alpha-L-iduronidase premature stop codons and potential read-through in mucopolysaccharidosis type I patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100012

7 January 2021

Correction of ATM gene function by aminoglycoside-induced read-through of premature termination codons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100012

7 January 2021

Expression of CTNS alleles: subcellular localization and aminoglycoside correction in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100012

7 January 2021

Aminoglycoside-mediated suppression of nonsense mutations in late infantile neuronal ceroid lipofuscinosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100012

7 January 2021

Gentamicin-Induced Correction of CFTR Function in Patients with Cystic Fibrosis andCFTRStop Mutations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100012

7 January 2021

Aminoglycoside suppression of nonsense mutations in severe hemophilia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100012

7 January 2021

Intracellular readthrough of nonsense mutations by aminoglycosides in coagulation factor VII.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100012

7 January 2021

Aminoglycoside-mediated rescue of a disease-causing nonsense mutation in the V2 vasopressin receptor gene in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100012

7 January 2021

Aminoglycosides as potential pharmacogenetic agents in the treatment of Hailey-Hailey disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100012

7 January 2021

Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100012

7 January 2021

Expression of SPCA1 (Hailey-Hailey disease gene product) in acantholytic dermatoses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100012

7 January 2021

Gentamicin treatment in McArdle disease: Failure to correct myophosphorylase deficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100012

7 January 2021

Enhanced production of functional proteins from defective genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100012

7 January 2021

Identifiers

DOI

10.1038/SJ.CLPT.6100012

1 reference

15 August 2017

1 reference